SETD2 and cancer: The discovered feedback loops predict both overall and relapse-free patient survival within the most aggressive UVM subtype, explain sensitivity to therapeutic gene perturbations, and inform effective combinatorial therapies.<h4>Conclusions</h4><i>SETD2</i> deletion potentiates isochromosome formation across diverse cancers.